Surgeons at Northwestern Medicine performed the first RAPID liver transplant in the U.S., successfully splitting a deceased donor’s liver to save two patients. One recipient, Barclay Missen, had stage IV colorectal cancer with liver metastases and remains cancer-free five months post-transplant. The procedure, inspired by European techniques, allows part of the donor liver to regenerate in the patient’s body before removing the diseased portion, offering a new lifeline for thousands facing liver metastases. Northwestern launched the CLEAR clinical trial to further study the approach, which could also reduce risks for living liver donors in the future.
Trending
- 5 doctors weigh in on the promise, limitations of Grail’s multicancer test (Medtech Dive)
- IBS Pain Closely Linked to Interrelated Daily-Life Triggers (Physicians Weekly)
- First and Only Ulcerative Colitis Treat-to-Target Trial Shows Treating to Disease Clearance vs. Symptomatic Remission with ENTYVIO® (vedolizumab) Prolongs Time to First Disease-Related Complication (Takeda)
- Industry Voices—How physician practices can grow and succeed without the support of private equity (Fierce Healthcare)
- Blood-Based CRC Test Upgrades Improve on Precancerous Lesion Detection (Medscape)
- Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard® and Closes $15 Million Financing (Lucid Diagnostics)
- How Can GI Fellowship Programs Enhance Ambulatory Training? (Yale School of Medicine)
- VIOVOC Issued U.S. Patent for Ambient Sensing Technology That Decodes Gut Microbiome Signals (Business Wire)
